The FDA announced on 2021-02-19 that Noven Pharmaceuticals Inc is recalling Daytrana (methylphenidate transdermal system) patches due to a defective delivery system. The agency stated the product poses a hazard because it is out of specification for mechanical peel.
How to tell if you have it
- Brand: Noven
- Product: Daytrana (methylphenidate transdermal system)
- Strength: Delivers 30 mg over 9 hours (3.3 mg/hr)
- Quantity: 30 Patches in a foil-sealed polypropylene tray, packed in a paper carton
- NDC: 68968-5555-3
- Lots #: 87377, Exp 3/2021; 87572, Exp 3/2021; 87581, Exp 4/2021; 87820, Exp 5/2021; 88246, Exp 6/2021; 88535, Exp 7/2021; 88536, Exp 8/2021; 88537, Exp 8/2021; 88939, Exp 8/2021
- Distribution: Nationwide in the USA
The hazard
According to the FDA, the Daytrana patches have a defective delivery system that is out of specification for mechanical peel. The recall involves 934,140 patches distributed nationwide.
Context
GovInfoNow's records show Noven Pharmaceuticals Inc has 24 other recalls on record since 2011-07-05. Other recent recalls of similar products include Noven Xelstrym 13.5mg Transdermal System Recall (2024-10-31), Noven Daytrana 30mg Transdermal System Recall (2023-03-10), and Noven Daytrana patches recalled due to defective adhesive delivery (2022-11-16). Other recent recalls of similar products include Bionpharma Divalproex Tablets Recall (2026-06-26), Xyvona (Levorphanol) 2mg Tablet Recall (2026-05-22), and Blossom Pharmaceuticals Dynashield Skin Protectant Recall (2025-10-31).